title: Challenges in detecting magnesium stearate distribution in tablets.
abstract: Magnesium stearate (MS) is the most commonly used lubricant in pharmaceutical industry. During blending, MS particles form a thin layer on the surfaces of the excipient and drug particles prohibiting the bonding from forming between the particles. This hydrophobic layer decreases the tensile strength of tablets and prevents water from penetrating into the tablet restraining the disintegration and dissolution of the tablets. Although overlubrication of the powder mass during MS blending is a well-known problem, the lubricant distribution in tablets has traditionally been challenging to measure. There is currently no adequate analytical method to investigate this phenomenon. In this study, the distribution of MS in microcrystalline cellulose (MCC) tablets was investigated using three different blending scales. The crushing strength of the tablets was used as a secondary response, as its decrease is known to result from the overlubrication. In addition, coating of the MCC particles by MS in intact tablets was detected using Raman microscopic mapping. MS blending was more efficient in larger scales. Raman imaging was successfully applied to characterize MS distribution in MCC tablets despite low concentration of MS. The Raman method can provide highly valuable visual information about the proceeding of the MS blending process. However, the measuring set-up has to be carefully planned to establish reliable and reproducible results.
authors: Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, P.O. Box 56, 00014, Helsinki, Finland. satu.lakio@helsinki.fi
authors: Satu
authors: S
authors: Lakio
authors: Balázs
authors: B
authors: Vajna
authors: István
authors: I
authors: Farkas
authors: Henri
authors: H
authors: Salokangas
authors: György
authors: G
authors: Marosi
authors: Jouko
authors: J
authors: Yliruusi
mesh_terms: D003460:Crystallization; D008855:Microscopy, Electron, Scanning; D013059:Spectrum Analysis, Raman; D013229:Stearic Acids / Q000032:analysis*; D013607:Tablets
chemical_list: D013229:Stearic Acids; D013607:Tablets; C031183:stearic acid
references: J Pharm Sci. 1977 Oct;66(10):1377-8
references: 925889
references: Appl Spectrosc. 2005 Mar;59(3):340-7
references: 15901316
references: Pharm Acta Helv. 1977;52(3):33-9
references: 918125
references: Int J Pharm. 2007 May 24;336(2):338-45
references: 17289312
references: Cytometry A. 2006 Aug 1;69(8):815-24
references: 16680705
references: Drug Dev Ind Pharm. 2012 Apr;38(4):412-9
references: 21954869
references: J Pharm Biomed Anal. 2010 Jan 5;51(1):30-8
references: 19709837
references: Int J Pharm. 2010 Sep 15;397(1-2):19-26
references: 20600718
references: Drug Dev Ind Pharm. 2003 Jul;29(6):679-87
references: 12889786
references: Appl Spectrosc. 2005 May;59(5):630-8
references: 15969808
references: Appl Spectrosc. 2006 Nov;60(11):1247-55
references: 17132441
references: J Am Pharm Assoc Am Pharm Assoc. 1956 Jan;45(1):51-5
references: 13278264
references: Analyst. 2003 Nov;128(11):1331-5
references: 14700225
references: Appl Spectrosc. 2007 Mar;61(3):239-50
references: 17389063
references: Int J Pharm. 2010 Oct 31;399(1-2):19-30
references: 20667504
references: Acta Pharm Hung. 1998 Nov;68(6):336-44
references: 9987197
references: Int J Pharm. 1999 Mar 1;179(1):107-15
references: 10053207
references: J Pharm Pharmacol. 1981 Dec;33(12):790
references: 6121852
references: J Pharm Biomed Anal. 2009 Apr 5;49(3):858-61
references: 19195812
references: J Pharm Pharmacol. 1986 Jan;38(1):51-4
references: 2869127
references: J Pharm Biomed Anal. 2008 Jan 22;46(2):274-81
references: 17980994
references: Pharm Weekbl Sci. 1987 Feb 20;9(1):24-8
references: 3562199
references: Int J Pharm. 2007 Dec 10;345(1-2):108-15
references: 17604924
references: J Pharm Sci. 2012 Jun;101(6):2229-38
references: 22437550
references: Analyst. 2002 Sep;127(9):1261-6
references: 12375854